Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Verena Krähling

Head of the Immunomonitoring Laboratory

Philipps-Universität Marburg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Articles (9)

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (8)

Leonie Marie Weskamm

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Eva Böttcher-Friebertshäuser

Philipps-Universität Marburg

GERMANY

View details

Bart L. Haagmans

Associate Professor - PhD - FESCMID

Erasmus MC

NETHERLANDS

View details

Alexandra Kupke

institute for medical microbiology and hygiene philipps‐university marburg marburg germany

GERMANY

View details

Wolfgang Hammerschmidt

Head of Unit

Helmholtz Zentrum München

GERMANY

View details

Johannes Roessler

University Hospital, LMU Munich

GERMANY

View details

Felix F Loeffler

Professor

Hamburg University of Technology

GERMANY

View details

Sibylle Mellinghoff

University Hospital Bonn

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Verena Krähling

Research Interests

Explore related searches

Articles (9)

Side-by-side evaluation of two Crimean-Congo hemorrhagic fever virus isolates in IFNAR−/− mice

Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage

MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans

Identification of a Spike-Specific CD8+ T-Cell Epitope Following Vaccination Against the Middle East Respiratory Syndrome Coronavirus in Humans.

Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial.

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans

MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity.

Quantitative assay to analyze neutralization and inhibition of authentic Middle East respiratory syndrome coronavirus

SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests

Collaborators (8)

Leonie Marie Weskamm

Eva Böttcher-Friebertshäuser

Bart L. Haagmans

Alexandra Kupke

Wolfgang Hammerschmidt

Johannes Roessler

Felix F Loeffler

Sibylle Mellinghoff

Make your next move.